These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2826714)

  • 1. A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancer.
    Eagan RT; Frytak S; Richardson RL; Creagan ET; Therneau TM; Coles DT; Jett JR
    J Clin Oncol; 1988 Jan; 6(1):5-8. PubMed ID: 2826714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
    Chahinian AP; Propert KJ; Ware JH; Zimmer B; Perry MC; Hirsh V; Skarin A; Kopel S; Holland JF; Comis RL
    J Clin Oncol; 1989 Aug; 7(8):993-1002. PubMed ID: 2547030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.
    Daniels JR; Chak LY; Sikic BI; Lockbaum P; Kohler M; Carter SK; Reynolds R; Bohnen R; Gandara D; Yu J
    J Clin Oncol; 1984 Nov; 2(11):1192-9. PubMed ID: 6092554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-small-cell lung cancer (NSCLC): chemotherapy in advanced disease. Our experience in ten years.
    Gonzalez Baron M; Garcia Giron C; Zamora P; Garcia de Paredes ML; Feliu J; Ordoñez A; Artal A; Garrido P; Chacon JI
    Am J Clin Oncol; 1992 Feb; 15(1):23-8. PubMed ID: 1312769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M; Kiura K; Okabe K; Toki H; Kimura M
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
    Bonomi PD; Finkelstein DM; Ruckdeschel JC; Blum RH; Green MD; Mason B; Hahn R; Tormey DC; Harris J; Comis R
    J Clin Oncol; 1989 Nov; 7(11):1602-13. PubMed ID: 2553879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study.
    Weick JK; Crowley J; Natale RB; Hom BL; Rivkin S; Coltman CA; Taylor SA; Livingston RB
    J Clin Oncol; 1991 Jul; 9(7):1157-62. PubMed ID: 1646292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non small cell lung cancer (NSCLC). A prospective randomized trial with alternating chemotherapy CEP/MEC' versus no treatment.
    Cellerino R; Tummarello D; Porfiri E; Guidi F; Isidori P; Raspugli M; Biscottini B; Fatati G
    Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1839-43. PubMed ID: 2851443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.
    Viallet J; Ihde DC
    J Clin Oncol; 1989 Aug; 7(8):985-7. PubMed ID: 2547029
    [No Abstract]   [Full Text] [Related]  

  • 10. Non small cell lung cancer and chemotherapy.
    Nardini S
    Monaldi Arch Chest Dis; 1994 Apr; 49(2):177-8. PubMed ID: 8049706
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.
    Cellerino R; Tummarello D; Guidi F; Isidori P; Raspugli M; Biscottini B; Fatati G
    J Clin Oncol; 1991 Aug; 9(8):1453-61. PubMed ID: 1649267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of the three-drug combination of mitomycin C, CCNU, and methotrexate (MCM) in advanced non-small cell lung cancer.
    Eagan RT; Frytak S; Richardson RL; Creagan ET; Nichols WC
    Am J Clin Oncol; 1986 Feb; 9(1):67-70. PubMed ID: 3082180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
    Ruckdeschel JC; Finkelstein DM; Ettinger DS; Creech RH; Mason BA; Joss RA; Vogl S
    J Clin Oncol; 1986 Jan; 4(1):14-22. PubMed ID: 3510278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer.
    Cartei G; Cartei F; Cantone A; Causarano D; Genco G; Tobaldin A; Interlandi G; Giraldi T
    J Natl Cancer Inst; 1993 May; 85(10):794-800. PubMed ID: 8387607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
    Chahinian AP; Green G; Holland JF
    Am J Clin Oncol; 1984 Oct; 7(5):419-23. PubMed ID: 6439029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancer.
    Krook JE; Jett JR; Fleming TR; Dalton RJ; Marschke RF; Cullinan SA; Windschitl HE; Everson LK; Brunk FS; Laurie JA
    J Clin Oncol; 1985 Jun; 3(6):842-8. PubMed ID: 3839263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MEP therapy of advanced lung cancer].
    Komuro Y; Ohnishi M; Saitoh A; Morohashi Y
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2688-91. PubMed ID: 2820313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current chemotherapy of small cell lung cancer.
    Livingston RB
    Chest; 1986 Apr; 89(4 Suppl):258S-263S. PubMed ID: 3007042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.